Cutting edge: transgenic expression of human MUC1 in IL-10-/- mice accelerates inflammatory bowel disease and progression to colon cancer.
Cutting edge: transgenic expression of human MUC1 in IL-10-/- mice accelerates inflammatory bowel disease and progression to colon cancer. Research Abstract Details
Cutting edge: transgenic expression of human MUC1 in IL-10-/- mice accelerates inflammatory bowel disease and progression to colon cancer. Abstract Text:
Epithelial cell MUC1 is aberrantly expressed on human epithelial adenocarcinomas where it functions as a regulator of immune responses and an oncogene. Normally expressed at low levels in healthy colonic epithelium, MUC1 was reported to be overexpressed in human inflammatory bowel disease (IBD) and thus may be expected to play an important role in regulating chronic inflammation and its progression to colitis-associated colon cancer. Studies in the immunobiology and pathology of IBD and colitis-associated colon cancer have been done in various mouse models but none could properly address the role of MUC1 due to low homology between the mouse and the human molecule. We report that IL-10(-/-) mice, a widely accepted mouse model of IBD, crossed to human MUC1-transgenic mice, develop MUC1(+) IBD characterized by an earlier age of onset, higher inflammation scores, and a much higher incidence and number of colon cancers compared with IL-10(-/-) mice.
Cutting edge: transgenic expression of human MUC1 in IL-10-/- mice accelerates inflammatory bowel disease and progression to colon cancer. Publishing Authors By Initials
Cutting edge: transgenic expression of human MUC1 in IL-10-/- mice accelerates inflammatory bowel disease and progression to colon cancer. Journal Published:
PUBLICATION TYPE: Research Support, N.I.H., Extr
Journal: Journal of immunology (Baltimore, Md. : 1950)
VOLUME: 179
Page Numbers: 735-9
Journal Abbreviation: J. Immunol.
ISSN: 0022-1767
DAY: 15
MONTH: Jul
YEAR: 2007
Cutting edge: transgenic expression of human MUC1 in IL-10-/- mice accelerates inflammatory bowel disease and progression to colon cancer. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 2985117
Cutting edge: transgenic expression of human MUC1 in IL-10-/- mice accelerates inflammatory bowel disease and progression to colon cancer. Keywords Mesh Terms:
KEYWORDS: Precancerous Conditions
MESH TERMS: pathology
Chemical & Substance for Abstract: Cutting edge: transgenic expression of human MUC1 in IL-10-/- mice accelerates inflammatory bowel disease and progression to colon cancer. Information
Substance Name: Interleukin-10
Registry Number: 130068-27-8
Grant and Affiliation Information for Cutting edge: transgenic expression of human MUC1 in IL-10-/- mice accelerates inflammatory bowel disease and progression to colon cancer.
AFFILIATION: Department of Immunology, University of Pittsburgh School of Medicine, PA 15261, USA.
Country: United States
AGENCY: United States NCI
GRANT: CA47904-17
ACRONYM: CA
MEDLINETA: J Immunol
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Cutting edge: transgenic expression of human MUC1 in IL-10-/- mice accelerates inflammatory bowel disease and progression to colon cancer Related Publications